This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marichal, P.
Right arrow Articles by Vanden Bossche, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marichal, P.
Right arrow Articles by Vanden Bossche, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1999, p. 2663-2670, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Accumulation of 3-Ketosteroids Induced by Itraconazole in Azole-Resistant Clinical Candida albicans Isolates

Patrick Marichal,1,2,* Jos Gorrens,1 Leen Laurijssens,1 Karen Vermuyten,1 Carl Van Hove,3 Ludo Le Jeune,4 Peter Verhasselt,5 Dominique Sanglard,6 Marcel Borgers,2 Frans C. S. Ramaekers,2 Frank Odds,1,dagger and Hugo Vanden Bossche1

Anti-Infectives Research Departments,1 Immunology Department,3 Analytical Department,4 and Biotechnology Department,5 Janssen Research Foundation, Beerse, Belgium; Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland6; and Department of Molecular Cell Biology & Genetics, University Maastricht, Maastricht, The Netherlands2

Received 20 May 1999/Returned for modification 11 August 1999/Accepted 1 September 1999

The effects of itraconazole on ergosterol biosynthesis were investigated in a series of 16 matched clinical Candida albicans isolates which had been previously analyzed for mechanisms of resistance to azoles (D. Sanglard, K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents Chemother., 39:2378-2386, 1995). Under control conditions, all isolates contained ergosterol as the predominant sterol, except two strains (C48 and C56). In isolates C48 and C56, both less susceptible to azoles than their parent, C43, substantial concentrations (20 to 30%) of 14alpha -methyl-ergosta-8,24(28)-diene-3beta ,6alpha -diol (3,6-diol) were found. Itraconazole treatment of C43 resulted in a dose-dependent inhibition of ergosterol biosynthesis (50% inhibitory concentration, 2 nM) and accumulation of 3,6-diol (up to 60% of the total sterols) together with eburicol, lanosterol, obtusifoliol, 14alpha -methyl-ergosta-5,7,22,24(28)-tetraene-3beta ol, and 14alpha -methyl-fecosterol. In strains C48 and C56, no further increase of 3,6-diol was observed after exposure to itraconazole. Ergosterol synthesis was less sensitive to itraconazole inhibition, as was expected for these azole-resistant isolates which overexpress ATP-binding cassette transporter genes CDR1 and CDR2. In addition to 3,6-diol, substantial amounts of obtusifolione were found after exposure to itraconazole. This toxic 3-ketosteroid was demonstrated previously to accumulate after itraconazole treatment in Cryptococcus neoformans and Histoplasma capsulatum but has not been reported in Candida isolates. Accumulation of obtusifolione correlated with nearly complete growth inhibition in these azole-resistant strains compared to that found in the susceptible parent strain, although the onset of growth inhibition only occurred at higher concentrations of itraconazole. ERG25 and ERG26 are the only genes assigned to the 4-demethylation process, of which the 3-ketoreductase is part. To verify whether mutations in these ERG25 genes contributed to obtusifolione accumulation, their nucleotide sequences were determined in all three related isolates. No mutations in ERG25 alleles of isolates C48 and C56 were found, suggesting that this gene is not involved in obtusifolione accumulation. The molecular basis for the accumulation of this sterol in these two strains remains to be established.


* Corresponding author. Mailing address: Janssen Research Foundation Infectious Diseases Research Departments, Turnhoutseweg 30, B2340 Beerse, Belgium. Phone: 32 14 60 31 97. Fax: 32 14 60 54 03. E-mail: pmaricha{at}janbe.jnj.com.

dagger Present address: Department of Molecular Cell Biology, University of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, Scotland.


Antimicrobial Agents and Chemotherapy, November 1999, p. 2663-2670, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Parker, J. E., Merkamm, M., Manning, N. J., Pompon, D., Kelly, S. L., Kelly, D. E. (2008). Differential Azole Antifungal Efficacies Contrasted Using a Saccharomyces cerevisiae Strain Humanized for Sterol 14{alpha}-Demethylase at the Homologous Locus. Antimicrob. Agents Chemother. 52: 3597-3603 [Abstract] [Full Text]  
  • Munayyer, H. K., Mann, P. A., Chau, A. S., Yarosh-Tomaine, T., Greene, J. R., Hare, R. S., Heimark, L., Palermo, R. E., Loebenberg, D., McNicholas, P. M. (2004). Posaconazole Is a Potent Inhibitor of Sterol 14{alpha}-Demethylation in Yeasts and Molds. Antimicrob. Agents Chemother. 48: 3690-3696 [Abstract] [Full Text]  
  • Vanden Bossche, H., Ausma, J., Bohets, H., Vermuyten, K., Willemsens, G., Marichal, P., Meerpoel, L., Odds, F., Borgers, M. (2004). The Novel Azole R126638 Is a Selective Inhibitor of Ergosterol Synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob. Agents Chemother. 48: 3272-3278 [Abstract] [Full Text]  
  • Barker, K. S., Pearson, M. M., Rogers, P. D. (2003). Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother 51: 1131-1140 [Abstract] [Full Text]  
  • De Backer, M. D., Ilyina, T., Ma, X.-J., Vandoninck, S., Luyten, W. H. M. L., Vanden Bossche, H. (2001). Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray. Antimicrob. Agents Chemother. 45: 1660-1670 [Abstract] [Full Text]